CROHN’S DISEASE
Doctors are seeking participants for a clinical study to evaluate Etrolizumab as an induction and maintenance treatment.

LEARN MORE

ALZHEIMER’S STUDY
A global research study needs people aged 50 to 85 concerned by their memory changes. If you or someone you know is experiencing memory loss or has early Alzheimer’s disease, you may qualify and receive at no cost

LEARN MORE

IRON DEFICIENCY ANEMIA
Iron deficiency anemia is a type of anemia that commonly occurs after significant blood loss from a disease or medical condition. The loss of iron means that your blood cells can’t carry enough oxygen, which often leaves you tired and breathless

LEARN MORE

SICKLE CELL ANEMIA
Study of new drug to help in the prevention of Sickle Cell Crisis. Patients over the age of 16 who are experiencing some active sickle cell complication, taking controlled doses of narcotic pain medication will be randomized into a 4 arm

LEARN MORE

H. PYLORI
A study to compare active drug combinations in participants with upper gastrointestinal symptoms

LEARN MORE

BREAST CANCER
Patient must have histologically confirmed invasive triple-negative adenocarcinoma of the breast with tumor ages greater than 18 years old.

LEARN MORE

CIRRHOSIS
Patients must have a confirmed diagnosis of NASH and a fibrosis score of 4 based on NASH CRN scoring system determined by central reading of liver biopsy obtained no more than 12 months before beginning study ages greater than 18 years old.

LEARN MORE

Trial for CKD induced Anemia Patients receiving dialysis

Open-label to evaluate efficacy and safety of Daprodustat compared to recombinant Human Erythropoietin, following switch from Erythropoietin-stimulating agents.